Neurology

The FDA today expanded the indication of Allergan's onabotulinumtoxinA (Botox), allowing the drug to be used for the treatment of upper limb spasticity in adults.

Researchers find biological evidence of repaired myelin.

New drug is the first approved generic of Copaxone.

The FDA today approved Sandoz's glatiramer acetate (Glatopa), a once-daily injection indicated for relapsing forms of multiple sclerosis.

Increased neuron activity helps to protect nerve fibers.

Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses methods specialty pharmacies can use to enhance adherence in patients with multiple sclerosis.

Procedure may be more effective than leading drug mitoxantrone.

Shire's ADHD treatment, lisdexamfetamine dimesylate (Vyvanse), is now available in a 10-mg titration dose.

Epilepsy has scores of factors, each leading to different treatment strategies and complicating the development of an evidence-based approach to seizure control.

Newly characterized compounds found to block inflammation and nerve cell damage.

Patients found to less antioxidant and anti-inflammatory nutrients.

Study identifies drug candidates to promote differentiation and myelin production.

Study examines link between caffeine intake and reduced symptoms of multiple sclerosis.

Casting doubt on previous conjectures, a new study suggests that statins do not protect patients against Parkinson's disease.

Compared with those receiving short-acting antiepileptic drugs (AEDs), patients with epilepsy taking long-acting AEDs use fewer health care services and have lower related care costs.

Availability of a raw methamphetamine ingredient in popular OTC products prompted national regulations to move products that contain pseudoephedrine behind the pharmacy counter.

Expanded use includes patients newly diagnosed with the disease.

Scientists map pathological progress of disease.

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis.

In 2014, the FDA approved notable new therapies for the treatment of cancer, bleeding disorders, inflammatory conditions, cystic fibrosis, pulmonary fibrosis, HIV, hepatitis C, multiple sclerosis, angioedema, and other conditions.

Former National Football League players who participated in tackle football before the age of 12 were more likely to have memory and thinking problems in adulthood.

Researchers gain insight into the cause of fatigue in MS patients.

In a friend-of-the-court brief filed today with the U.S. Supreme Court in the case of King v. Burwell, leading groups fighting chronic disease provide scientific evidence of the grave consequences if millions of people nationwide were to lose the tax credits provided under the Affordable Care Act that provide the financial assistance they need to afford health coverage.

MuckFest® MS will be featured on an upcoming episode of The Bachelor. The episode will feature an exciting group date through the MuckFest MS fun mud and obstacle 5K course with the newest Bachelor, Chris Soules, and contestants racing through the mud in wedding dresses. The episode is scheduled to air Monday, January 26, 2015, at 8/7c on ABC.

Stem cell transplantation associated with improvements in disability measures and quality of life.

Researchers find no link between neurologic ailments and quadrivalent HPV vaccination.

Most patients treated with high-dose immunosuppressive therapy and who had their own hematopoietic stem cells transplanted experienced sustained remission after 3 years.

While some researchers have associated human papillomavirus vaccination with an increased risk for multiple sclerosis, a new study found no such link between the vaccine and the development of demyelinating disease.